who makes the glp 1 drugs Chart: in 8 Americans Now Use GLP-1 for Weight Loss How GLP-1 medications are transforming
Description
The concern with these medications is that the delayed gastric emptying leads to residual gastric contents, which may increase the risk of aspiration
This caution is based on findings from animal studies and limited human case reports
Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in beta-cell glutamate signaling for incretin-induced insulin secretion
The role of glucagon in maintaining glucose homeostasis by increasing hepatic gluconeogenesis and glycogenolysis in response to low glucose levels has been exhaustively studied
